Delivery Order SPE2DB22D1017-SPE2DB24FG3XM

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (tirzepatide) 10 mg/0.5 mL pens. The award, valued at $1,578, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) worth up to $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a $9,319.47 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the prescription drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The $45,378.33 firm fixed-price contract has an ultimate completion date of October 24, 2024. AmerisourceBergen, a for-profit corporate entity registered in the System for Award Management (SAM.gov), has an extensive history of federal contract awards with DLA and other agencies,...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,264.76 contract is for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The award has a completion date of March 13, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen. The award, valued at $5,155.20, is a firm-fixed-price contract with a performance period ending on May 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Mounjaro (tirzepatide) 5 mg/0.5 ml pen. The $3,156 firm fixed-price delivery order has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the drug Mounjaro (tirzepatide) 5 mg/0.5 ml pen. The contract, valued at $3,757.37, is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,035.35, is for the delivery of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The contract is a Firm Fixed Price, non-set-aside award with a completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of the drug Mounjaro (generic name: tirzepatide) in a 15 mg/0.5 mL pen dosage form. The award, valued at $1,113.05, is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics and technical services to the U.S. Armed Forces. The contract is a firm-fixed price arrangement with a completion date of June 26, 2024....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $1,127.88 and a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3XM
    Delivery Order

This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of the prescription drug Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The $1,315 award is a delivery order issued under a broader Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The current delivery order has an ultimate completion date of August 27, 2024 and is a firm fixed-price contract. The contract does not have a set-aside designation.

Generated 11/25/24, 9:27 AM